Noninvasive ventilation – sleep breathing related disorders and obesity hypoventilation syndrome – pulmonary rehabilitation - intensive care medicine - COPD
He is received Medical degree from University of Genoa.He is board certified in pulmonary diseases and respiratory pathophysiology and rehabilitation. He is currently Director of Respiratory Diseases Unit ,Hospital of Sestri Levante – Italy , and Professor of Pulmonolgy at Physiotherapy and Physical Medicine , University of Genoa. He is currently Secretary of Study group of Intensive Care of italian Society of Pulmonology (ISP). He is author of over 100 peer reviewed articles and several book-chapters. He is a reviewer for multiple International journal in the fiels of respiratory diseases.
Breast pathology; Molecular pathology; Gynecopathology; Digestive and Liver disease; Uropathology and Head and Neck pathology
Dr. Alessandro DAmuri completed his degree in Medicine and Surgery at the University of Siena (Italy) in 1998-1999. Speciality degree (2004-2005) in Anatomical Pathology at the University of Siena. PhD in Medical Biotechnology (2011) at the University of Siena. Engaged in the following research program: Breast cancer: tumor cell dissemination and metastasization; CDK9/Cyclin T1 complex role in lymphoid cells differentiation; Repertoire analysis of immunoglobulins genes during allograft rejection episodes of kidney transplants. Medical Director at the Anatomic Pathology Unit "Card. G. Panico" Hospital Tricase (Lecce, Italy); about 60.000 diagnosed signed until now, concerning cytology and histologic biopsies and surgical specimens. Expertise in breast pathology, uropathology, gynecopathology, head and neck pathology, digestive tract pathology and molecular pathology. Winner of the prize for the best Oral Communication at the IX National Congress of Italian Society of Cytology (2009). Attended at Molecular Pathology training in Microarray Systems for Molecular Biology, Genotyping HPV tests "KIT DR Chip HPV N3" (2010).
pre-clinical and clinical research, in the field of cancer immunotherapy and in the study host response to cancer. Development of novel tracers for PET/ MRI and SPECT/CT imaging of cancer, including radiolabelled monoclonal antibodies/ Ab fragments, cytokines and different immune cell subsets.